Immunovant, Inc. Common Stock
$33.30
▼ 0.70
(-2.06%)
Volume: 2,083,971
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
13
- 21d momentum -24.1%
- MA aligned bearish
- RSI 25 oversold
🎯
Pullback
71
- RSI 25 near lows
- Near lower Bollinger band
- -11.8% vs 20MA
💎
Value
58
- -27% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)25.1
MACD-0.477
MA trendBearish
ATR4.55%
21d mom.-24.1%
63d mom.-14.3%
vs 20MA-11.8%
RVOL(20)1.41×
52w low · 16
52w high · 45
-26.7% from 52-week high
20d support 33
· resistance 43
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$7.0B
PER—
PBR9.55
PSR—
EPS$-2.61
ROE-73.2%
ROA-63.1%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA-11.01
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| -9.88% | -24.13% | -14.29% | +31.31% | +115.39% | +28.52% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -15.16%, daily vol 2.33%. Immunovant, Inc. Common Stock sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.